Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Noonan Syndrome 1Melanoma 1Esophageal Squamous Cell Carcinoma 1

Interventions

Specimen Handling 149pembrolizumab 123Magnetic Resonance Spectroscopy 120Cyclophosphamide 115Biopsy 98fludarabine 90Nivolumab 53Carboplatin 53Cisplatin 48Gemcitabine 46Radiotherapy 41venetoclax 40fludarabine phosphate 40Paclitaxel 40Cetuximab 40Ipilimumab 34atezolizumab 33Fluorouracil 33Bevacizumab 33Oxaliplatin 27Leucovorin 27X-Rays 26Dexamethasone 26durvalumab 25Irinotecan 25Radiation 24Cytarabine 24Azacitidine 24Injections 23Pemetrexed 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × nazartinib × 90 days × Clear all
NCT03114319 2026-04-16

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Novartis

Phase 1 Terminated
227 enrolled
DermatologicGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Melanoma, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡